Dana-Farber Researchers Receive AACR 2025 Scientific Achievement Awards
Years of Research Help Forge a New Path in Hodgkin Lymphoma Treatment
Building New Roads to a Melanoma Cure
Novel Genomic Screening Tool Enables Precision Reverse-Engineering of Genetic Programming in Cells
FDA Approves Dual-Action Drug for Patients with Previously Treated Advanced Neuroendocrine Tumors, Backed by Dana-Farber Research
Potential Targeted Therapy for Pediatric Brain Cancer Identified by Dana-Farber/Boston Children's Team
AI Learns Genomic “Language” to Advance Cancer Treatment
Treatment of Recurrent Endometrial Cancer with Metformin, Letrozole, and Abemaciclib is Safe and Promising, Dana-Farber Research Shows
Continuing to Advance the Standard of Care for Newly Diagnosed and Relapsed/Refractory Multiple Myeloma
Novel Approaches in Waldenström's Macroglobulinemia
Novel Stem Cell Therapy Safely Repairs Irreversible Corneal Damage in Clinical Trial
Mind and Body: Prioritizing Mental Health
Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber
Early Cancer Detection Studies for High-Risk People
Dana-Farber Researchers to Present Key Transplant and Cellular Therapy Studies at 2025 Tandem Meetings
Showing 121 - 135 of 1032 results
Previous| 1... 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 ...69 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
